Upregulated gene expression of ANP40 as well as the two growth factors, TGFβ1 and TGFβ213, observed in this study, are also well recognized transcriptional changes occurring during the development of cardiac hypertrophy. The gene discussed is TGFB1; the disease is cardiac hypertrophy.